November 10, 2025 — Leads & Copy — Cyanotech Corporation (OTCQB: CYAN) has released its financial results for the second quarter of fiscal year 2026, which ended on September 30, 2025.
According to Cyanotech President and CEO Matthew K. Custer, the second quarter saw continued momentum in both sales growth and profitability. Total sales increased 19.3% year-over-year due to higher bulk sales and strong performance in online channels.
The company also saw improvement in gross margin as production volumes increased, which drove down per-unit costs and improved overall efficiency. Price increases implemented earlier in the year for the Nutrex-brand products also contributed to margin expansion.
While tariffs impacted the company’s contract extraction competitiveness, Cyanotech is focused on operational excellence, disciplined cost control, and building a stronger and more resilient business for long-term success. Custer said that he is confident that Cyanotech is steadily moving in a positive direction due to continued momentum across its brands, improving profitability trends, and a dedicated team that continues to deliver results despite challenging market conditions.
Cyanotech reported net sales of $6,976,000 for the second quarter of fiscal 2026, compared to $5,845,000 for the second quarter of fiscal 2025, representing an increase of 19.3%. The gross profit was $2,393,000, with a gross profit margin of 34.3%, compared to $1,479,000 with a 25.3% gross profit margin. Operating income for the second quarter of fiscal 2026 was $190,000, compared to an operating loss of $975,000 in the same period of the prior year. Net income for the current fiscal quarter was $1,000, or $0.00 per diluted share, compared to a net loss of $1,150,000, or $0.16 per diluted share, for the same period of the prior year.
Net sales for the trailing twelve months ended September 30, 2025, were $25,269,000, compared to $23,295,000 for the trailing twelve months ended September 30, 2024. The gross profit was $8,086,000, with a gross profit margin of 32.0%, compared to $5,280,000 and 22.7%. The net loss was $1,776,000, or $0.25 per diluted share, compared to a net loss of $5,452,000, or $0.80 per diluted share.
Cyanotech will host a virtual broadcast on November 11, 2025, at 8:00 PM ET to respond to questions about its operating results and other topics of interest. Interested parties are asked to submit questions to questions@cyanotech.com before 12 p.m. (noon) ET on Tuesday, November 11, 2025. The Company will only respond to relevant questions relating to the Company’s second quarter fiscal 2026 financial performance and will not be accepting questions or comments during the broadcast.
To join the broadcast, go to http://cyanotech.com/meet approximately five minutes before the start time.
Cyanotech Corporation produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. The company’s mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech sells its products directly to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to dietary supplement, nutraceutical, and cosmeceutical manufacturers and marketers. The Company is regulated by the Food and Drug Administration.
Visit www.cyanotech.com for more information.
Contact: questions@cyanotech.com
Source: Cyanotech Corporation
